Thus, the BRCA2-associated risk could be higher for pancreatic than for breast cancer, as indicated by our analysis of pooled patients against gnomAD data (BRCA1: OR = 6.0 vs. BRCA2: OR = 11.7; Figure 1). The gene discussed is BRCA2; the disease is breast cancer.